These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18720036)

  • 1. Diagnosis and prediction of parental origin of triploidies by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11-14 weeks of gestation.
    Barken SS; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Brøndum-Nielsen K
    Acta Obstet Gynecol Scand; 2008; 87(9):975-8. PubMed ID: 18720036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation.
    Kagan KO; Anderson JM; Anwandter G; Neksasova K; Nicolaides KH
    Prenat Diagn; 2008 Dec; 28(13):1209-13. PubMed ID: 19039823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial).
    Dugoff L; Hobbins JC; Malone FD; Porter TF; Luthy D; Comstock CH; Hankins G; Berkowitz RL; Merkatz I; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Vidaver J; D'Alton ME
    Am J Obstet Gynecol; 2004 Oct; 191(4):1446-51. PubMed ID: 15507981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester nuchal translucency and maternal serum free beta-hCG and PAPP-A can detect triploidy and determine the parental origin.
    Yaron Y; Ochshorn Y; Tsabari S; Shira AB
    Prenat Diagn; 2004 Jun; 24(6):445-50. PubMed ID: 15229844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy].
    Gajewska J; Ceran A; Chełchowska M; Borowski D; Ambroszkiewicz J; Jaczyńska R; Zwoliński J; Laskowska-Klita T
    Przegl Lek; 2008; 65(10):479-82. PubMed ID: 19189527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of triploidy at 11-14 weeks' gestation: a cohort study of 198 000 pregnant women.
    Engelbrechtsen L; Brøndum-Nielsen K; Ekelund C; Tabor A; Skibsted L;
    Ultrasound Obstet Gynecol; 2013 Nov; 42(5):530-5. PubMed ID: 23494847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery.
    Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of maternal smoking on prenatal screening for Down syndrome and trisomy 18 in the first trimester of pregnancy.
    Miron P; Côté YP; Lambert J
    Prenat Diagn; 2008 Mar; 28(3):180-5. PubMed ID: 18264956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuchal translucency and combined test: what are the implications in clinical practice?].
    Marchini G; Rosati A; Ribiani E; Romanelli M; Porcaro G; Clerici G
    Minerva Ginecol; 2010 Jun; 62(3):187-93. PubMed ID: 20595943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical first-trimester routine screening for Down syndrome in singleton pregnancies in northern Finland.
    Valinen Y; Rapakko K; Kokkonen H; Laitinen P; Tekay A; Ahola T; Ryynanen M
    Am J Obstet Gynecol; 2007 Mar; 196(3):278.e1-5. PubMed ID: 17346554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Rhesus status on first-trimester pregnancy screening markers free beta human chorionic gonadotropin, pregnancy-associated plasma protein-A and nuchal translucency.
    Cowans NJ; Stamatopoulou A; Spencer K
    Prenat Diagn; 2009 May; 29(5):505-7. PubMed ID: 19222026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21.
    Nicolaides KH; Chervenak FA; McCullough LB; Avgidou K; Papageorghiou A
    Am J Obstet Gynecol; 2005 Aug; 193(2):322-6. PubMed ID: 16098850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
    Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.